Cargando…
The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd
Mycobacterial energy metabolism currently attracts strong attention as new target space for development of anti-tuberculosis drugs. The imidazopyridine Q203 targets the cytochrome bcc complex of the respiratory chain, a key component in energy metabolism. Q203 blocks growth of Mycobacterium tubercul...
Autores principales: | Lu, Ping, Asseri, Amer H., Kremer, Martijn, Maaskant, Janneke, Ummels, Roy, Lill, Holger, Bald, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805707/ https://www.ncbi.nlm.nih.gov/pubmed/29422632 http://dx.doi.org/10.1038/s41598-018-20989-8 |
Ejemplares similares
-
Response of Mycobacterium smegmatis to the Cytochrome bcc Inhibitor Q203
por: Chauhan, Priyanka, et al.
Publicado: (2022) -
Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo(3) solubilized in dodecyl-maltoside
por: Asseri, Amer H., et al.
Publicado: (2021) -
A fluorescence-based reporter for monitoring expression of mycobacterial cytochrome bd in response to antibacterials and during infection
por: Boot, Maikel, et al.
Publicado: (2017) -
Cytochrome bd Displays Significant Quinol Peroxidase Activity
por: Al-Attar, Sinan, et al.
Publicado: (2016) -
Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
por: Zhou, Shan, et al.
Publicado: (2021)